
The adverse effects of abnormalities in SLF2 and SMC5.
Image Credit: KyotoU / Sho Shibata
Scientific Frontline: Extended "At a Glance" Summary: SLF2 and SMC5 Dysfunction in Bone Marrow Disorders
The Core Concept: Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
Key Distinction/Mechanism: Mutations in SLF2 and SMC5, genes originally linked to the neurodevelopmental disorder Atelis syndrome, induce the activation of the tumor suppressor p53 protein, which subsequently leads to the premature aging and failure of hematopoietic stem cells.
Major Frameworks/Components:
- Utilization of patient-derived induced pluripotent stem cell (iPSC) lines carrying pathogenic SLF2 variants.
- Application of CRISPR-Cas9 gene editing to generate genetically corrected isogenic lines.
- In vitro and in vivo differentiation and evaluation of hematopoietic progenitor cells.
- Observation of p53 protein activation directly linked to premature hematopoietic stem cell aging.
.jpeg)

.jpg)
.jpg)









